Annals of B Pod: Anti-Xa Overdose
Taming the SRU
FEBRUARY 12, 2024
DISCUSSION Epidemiology and Background Rivaroxaban, along with other direct oral anticoagulants (DOACs), has become a mainstay of treatment for pro-thrombotic conditions since 2011. [1] This does not deviate from general resuscitation principles for acute hemorrhage. The patient is agitated on a backboard with C-collar in place.
Let's personalize your content